Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Ministry of Health Flags Off Critical Human Immunodeficiency Virus (HIV) Commodities at Mission for Essential Drugs and Supplies (MEDS) ...
Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.
But turning this crisis into an opportunity is possible. To mitigate the effects of the funding freeze, Bekker said swift ...
18h
AllAfrica on MSNJournalists Trained in Ethical Reporting to Boost HIV/Aids AwarenessAccurate and ethical journalism on HIV/AIDS plays a vital role in shaping public perceptions, encouraging behavioral change, and raising awareness. Misinformation or vague reporting, however, can ...
Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic ...
That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results